Published in J Infect Dis on July 01, 1978
Enzyme-linked immunosorbent assay for detection of respiratory syncytial virus infection: application to clinical samples. J Clin Microbiol (1982) 3.22
Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines. Infect Immun (1982) 2.61
Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection. J Clin Microbiol (1986) 2.09
Detection, pathogenesis, and therapy of respiratory syncytial virus infections. Clin Microbiol Rev (1988) 1.92
Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment. Clin Microbiol Rev (1999) 1.83
Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection. J Clin Microbiol (1986) 1.79
Cell-free and cell-bound antibody in nasal secretions from infants with respiratory syncytial virus infection. Infect Immun (1979) 1.70
Analysis of immunoglobulin G antibody responses after administration of live and inactivated influenza A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum. J Clin Microbiol (1987) 1.53
Infectivity of respiratory syncytial virus by various routes of inoculation. Infect Immun (1981) 1.50
Respiratory syncytial virus vaccines. Clin Microbiol Rev (1998) 1.38
Local and systemic antibody response to bovine respiratory syncytial virus infection and reinfection in calves with and without maternal antibodies. J Clin Microbiol (1987) 1.35
Genetic variability of group A human respiratory syncytial virus strains circulating in Germany from 1998 to 2007. J Clin Microbiol (2009) 1.21
The natural history of respiratory syncytial virus in a birth cohort: the influence of age and previous infection on reinfection and disease. Am J Epidemiol (2012) 1.21
Secretory immunological response in infants and children to parainfluenza virus types 1 and 2. Infect Immun (1980) 1.12
Viral infection of the lung: host response and sequelae. J Allergy Clin Immunol (2013) 1.01
Intranasal antibody prophylaxis for protection against viral disease. Clin Microbiol Rev (1999) 1.00
Intranasal monoclonal immunoglobulin A against respiratory syncytial virus protects against upper and lower respiratory tract infections in mice. Antimicrob Agents Chemother (1994) 0.98
Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections. Clin Microbiol Rev (1995) 0.97
Comparison of fluorescent-antibody, neutralizing-antibody, and complement-enhanced neutralizing-antibody assays for detection of serum antibody to respiratory syncytial virus. J Clin Microbiol (1981) 0.94
Effectiveness of enteric immunization in the development of secretory immunoglobulin A response and the outcome of infection with respiratory syncytial virus. J Virol (1991) 0.93
Immunity to RSV in Early-Life. Front Immunol (2014) 0.92
Development of antibody-dependent cell-mediated cytotoxicity in the respiratory tract after natural infection with respiratory syncytial virus. Infect Immun (1982) 0.92
Identifying infections with respiratory syncytial virus by using specific immunoglobulin G (IgG) and IgA enzyme-linked immunosorbent assays with oral-fluid samples. J Clin Microbiol (2008) 0.91
Intranasal administration of retinyl palmitate with a respiratory virus vaccine corrects impaired mucosal IgA response in the vitamin A-deficient host. Clin Vaccine Immunol (2014) 0.85
Cryopreservation of virus-infected cells for use in the fluorescent antibody to membrane antigen test. J Clin Microbiol (1980) 0.85
Double-stranded RNA-activated protein kinase regulates early innate immune responses during respiratory syncytial virus infection. J Interferon Cytokine Res (2010) 0.85
Characteristics of immunity induced by viral antigen or conferred by antibody via different administration routes. Clin Exp Immunol (2002) 0.83
Respiratory syncytial virus infections in infants affected by primary immunodeficiency. J Immunol Res (2014) 0.83
Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment. Clin Microbiol Rev (2017) 0.83
Virus-induced complement activation and neutrophil-mediated cytotoxicity against respiratory syncytial virus (RSV). Clin Exp Immunol (1984) 0.82
The cDNA-derived investigational human parainfluenza virus type 3 vaccine rcp45 is well tolerated, infectious, and immunogenic in infants and young children. Pediatr Infect Dis J (2011) 0.81
Nonhuman primate infants have an impaired respiratory but not systemic IgG antibody response following influenza virus infection. Virology (2014) 0.81
In vitro cell-dependent lysis of respiratory syncytial virus-infected cells mediated by antibody from local respiratory secretions. Clin Exp Immunol (1981) 0.80
Development of local immunity: role in mechanisms of protection against or pathogenesis of respiratory syncytial viral infections. Lung (1990) 0.80
Respiratory syncytial virus group-specific antibody response in nasopharyngeal secretions from infants and children after primary infection. Clin Diagn Lab Immunol (1994) 0.79
Ontogenesis of the formation of secretory antibodies to respiratory syncytial (RS) virus. Epidemiol Infect (1988) 0.77
Antibody response to respiratory syncytial virus infection in children <18 months old. Hum Vaccin Immunother (2016) 0.76
Evolution and transmission of stable CTL escape mutations in HIV infection. Nature (2001) 6.57
Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med (2010) 6.38
Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J Infect Dis (1985) 5.91
The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic children. J Pediatr (1973) 4.22
A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. N Engl J Med (2000) 4.14
Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells. Nature (1989) 3.54
Detection of respiratory syncytial virus in nasal secretions from infants by enzyme-linked immunosorbent assay. J Infect Dis (1979) 3.49
Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease. Proc Natl Acad Sci U S A (1967) 3.47
Enzyme-linked immunosorbent assay for detection of respiratory syncytial virus infection: application to clinical samples. J Clin Microbiol (1982) 3.22
DTP reactions and serologic response with a reduced dose schedule. J Pediatr (1984) 2.67
Defect in the wiring of reinforced laryngeal mask leading to airway obstruction. Anaesthesia (1999) 2.56
Coronavirus infection in acute lower respiratory tract disease of infants. J Infect Dis (1974) 2.55
Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group. N Engl J Med (1999) 2.51
Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children. J Exp Med (2000) 2.31
Concurrent circulation of antigenically distinct strains of respiratory syncytial virus during community outbreaks. J Infect Dis (1986) 2.26
Viral and bacterial infections in adults with chronic asthma. Am Rev Respir Dis (1979) 2.25
Mutational analysis of the leucine zipper-like motif of the human immunodeficiency virus type 1 envelope transmembrane glycoprotein. J Virol (1993) 2.21
A comparative study of virus isolation, polymerase chain reaction, and antigen detection in children of mothers infected with human immunodeficiency virus. J Pediatr (1990) 2.09
Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity. J Pediatr (1980) 2.07
Coronaviridae: second report. Intervirology (1978) 2.05
Apnea associated with respiratory syncytial virus infection in young infants. J Pediatr (1977) 2.00
Cardiac structure and function in children with human immunodeficiency virus infection treated with zidovudine. N Engl J Med (1992) 1.92
Chlamydial infection of mothers and their infants. J Pediatr (1979) 1.89
Summary of a workshop on new and useful methods in viral diagnosis. J Infect Dis (1978) 1.87
Absence of cardiac toxicity of zidovudine in infants. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study Group. N Engl J Med (2000) 1.87
Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked immunospot assay. J Virol (2000) 1.84
Growth in suckling-mouse brain of "IBV-like" viruses from patients with upper respiratory tract disease. Proc Natl Acad Sci U S A (1967) 1.82
Role of infection in chronic bronchitis. Am Rev Respir Dis (1976) 1.81
Early detection of human immunodeficiency virus on dried blood spot specimens: sensitivity across serial specimens. Women and Infants Transmission Study Group. J Pediatr (1996) 1.79
Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children. J Virol (2000) 1.79
Cell-free and cell-bound antibody in nasal secretions from infants with respiratory syncytial virus infection. Infect Immun (1979) 1.70
Seroepidemiologic studies of coronavirus infection in adults and children. Am J Epidemiol (1970) 1.66
Diphtheria-pertussis-tetanus vaccine: reactogenicity of commercial products. Pediatrics (1979) 1.65
Neonatal Haemophilus influenzae infection. Report of eight cases and review of the literature. Am J Dis Child (1975) 1.65
Cardiac morbidity and related mortality in children with HIV infection. JAMA (1993) 1.65
Bending-related faulting and mantle serpentinization at the Middle America trench. Nature (2003) 1.64
Interferon in nasal secretions from infants with viral respiratory tract infections. J Pediatr (1978) 1.61
Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics. J Clin Microbiol (1998) 1.58
Is it time to give influenza vaccine to healthy infants? N Engl J Med (2000) 1.58
Coronaviridae. Intervirology (1975) 1.55
Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus. J Infect Dis (1988) 1.52
Immunopathologic mechanisms in lower respiratory tract disease of infants due to respiratory syncytial virus. Prog Med Virol (1980) 1.51
Morphogenesis of avian infectious bronchitis virus and a related human virus (strain 229E). J Virol (1967) 1.49
The preparation and properties of adenovirus cores. J Gen Virol (1971) 1.49
Antigenic relationships among the coronaviruses of man and between human and animal coronaviruses. J Immunol (1969) 1.48
Measles mortality. Analysis of the primary cause of death. Am J Dis Child (1975) 1.46
Isolation from man of "avian infectious bronchitis virus-like" viruses (coronaviruses) similar to 229E virus, with some epidemiological observations. J Infect Dis (1969) 1.41
Early diagnosis of HIV infection in infants by detection of IgA HIV antibodies. Lancet (1990) 1.41
Evaluation of human and simian immunodeficiency virus plaque and neutralization assays. J Gen Virol (1989) 1.39
Altered histopathology in protein-deprived mice during Sendai virus pneumonia: evidence for delayed inflammatory response and recovery. J Infect Dis (1992) 1.39
Prevalence of respiratory syncytial virus subgroups over six consecutive outbreaks: 1981-1987. J Infect Dis (1989) 1.39
Measles mortality: a retrospective look at the vaccine era. Am J Epidemiol (1975) 1.38
Comprehensive screening reveals strong and broadly directed human immunodeficiency virus type 1-specific CD8 responses in perinatally infected children. J Virol (2003) 1.38
Treatment of respiratory viral infection in an immunodeficient infant with ribavirin aerosol. Am J Dis Child (1984) 1.38
A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants. J Virol (1999) 1.38
Mother-to-child transmission of HIV infection and CTL escape through HLA-A2-SLYNTVATL epitope sequence variation. Immunol Lett (2001) 1.37
Multicenter study of strains of respiratory syncytial virus. J Infect Dis (1991) 1.34
Comparison of cynomolgus and rhesus monkey kidney cells for recovery of viruses from clinical specimens. J Clin Microbiol (1979) 1.33
Cardiovascular manifestations of human immunodeficiency virus infection in infants and children. Am J Cardiol (1989) 1.33
Comparison of washed nasopharyngeal cells and whole nasal secretions for detection of respiratory syncytial virus antigens by enzyme-linked immunosorbent assay. J Clin Microbiol (1986) 1.28
Protective activity of a human respiratory syncytial virus immune globulin prepared from donors screened by microneutralization assay. J Infect Dis (1992) 1.27
Further characterization of the soluble form of the G glycoprotein of respiratory syncytial virus. J Virol (1988) 1.26
The association of rhinoviruses with lower respiratory tract disease in hospitalized patients. J Med Virol (1986) 1.23
Evaluation of a commercially available direct immunofluorescent staining reagent for the detection of respiratory syncytial virus in respiratory secretions. J Clin Microbiol (1986) 1.23
Growth and body composition in children infected with the human immunodeficiency virus-1. Am J Clin Nutr (1993) 1.22
Enzyme-linked immunosorbent assay for detection of respiratory syncytial virus infection: development and description. J Clin Microbiol (1982) 1.20
A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group. N Engl J Med (1991) 1.20
Monoclonal antibodies for the rapid diagnosis of respiratory syncytial virus infection by immunofluorescence. Diagn Microbiol Infect Dis (1984) 1.16
The prenatal exclusion test for Huntington's disease: experience in the west of Scotland, 1986-1993. J Med Genet (1995) 1.16
In vitro activities of penciclovir and acyclovir against herpes simplex virus types 1 and 2. Antimicrob Agents Chemother (1992) 1.13
Summary of a workshop on new and useful methods in rapid viral diagnosis. J Infect Dis (1984) 1.13
Appearance of a soluble form of the G protein of respiratory syncytial virus in fluids of infected cells. J Gen Virol (1987) 1.13
Identification of human immunodeficiency virus-1 RNA and DNA in the heart of a child with cardiovascular abnormalities and congenital acquired immune deficiency syndrome. Am J Cardiol (1990) 1.12
Secretory immunological response in infants and children to parainfluenza virus types 1 and 2. Infect Immun (1980) 1.12
A simultaneous outbreak of respiratory syncytial virus and parainfluenza virus type 3 in a newborn nursery. J Pediatr (1984) 1.12
Type A2 influenza viral infections in children. Am J Dis Child (1978) 1.12
The effect of protease inhibitor therapy on growth and body composition in human immunodeficiency virus type 1-infected children. Pediatrics (2001) 1.10
Prospective 5-year study of peripheral blood CD4, CD8, and CD19/CD20 lymphocytes and serum Igs in children born to HIV-1 women. The P(2)C(2) HIV Study Group. J Allergy Clin Immunol (2000) 1.09
VDAC/porin is present in sarcoplasmic reticulum from skeletal muscle. FEBS Lett (1996) 1.09
Characterization of a novel respiratory syncytial virus-specific human cytotoxic T-lymphocyte epitope. J Virol (2000) 1.09
Clinical and serologic study of four smallpox vaccines comparing variations of dose and route of administration. Standard percutaneous revaccination of children who receive primary percutaneous vaccination. J Infect Dis (1977) 1.08
Oral ribavirin therapy for subacute sclerosing panencephalitis. J Infect Dis (1989) 1.08
Selective primary health care: strategies for control of disease in the developing world. XXI. Acute respiratory infections. Rev Infect Dis (1985) 1.07
Oral administration of acetylcholine receptor: effects on experimental myasthenia gravis. Ann Neurol (1994) 1.07
The use of gowns and masks to control respiratory illness in pediatric hospital personnel. J Pediatr (1981) 1.06
Clinical and serologic study of four smallpox vaccines comparing variations of dose and route of administration. Primary percutaneous vaccination. J Infect Dis (1977) 1.05
Natural history of primary Epstein-Barr virus infection in children of mothers infected with human immunodeficiency virus type 1. J Infect Dis (1999) 1.04
Risk of illness after exposure to a pediatric office. N Engl J Med (1985) 1.04
Respiratory syncytial virus infections in infants and children: diagnosis and treatment. Pediatr Rev (1987) 1.03
Neonatal mastitis. Clin Pediatr (Phila) (1986) 1.03
Polymerase chain reaction in detecting HIV infection among seropositive infants: relation to clinical status and age and to results of other assays. J Acquir Immune Defic Syndr (1992) 1.03